Weei/nesn Jimmy Fund Radio-telethon

Sriram "Sri" Srikant (SHREE-ram "SHREE" SHREE-cant), 33, bile duct cancer, Cambridge, withThomas A. Abrams, MD, Institute Physician of Gastrointestinal Cancers, Dana-Farber· For a few months in early 2022, Shree was experiencing abdominal distress thatprogressively worsened. Eventually, he was unable to eat solid foods. He visited his primary carephysician who informed him that it looked like he had a large growth duct on his liver/pancreasleading to the digestive system. He initially hoped for surgery, but additional scans confirmedthat the cancer was metastatic.· For treatment, Shree started chemotherapy, radiation, and immunotherapy; since thenhe’s almost continuously been receiving immunotherapy and just restarted chemotherapy. Sideeffects have been minimal because of Shree’s young age and good health, according to hisdoctor, Dr. Abrams.· As a post-doctoral scientist at MIT, Shree has been able to understand and appreciatethe details of his journey, but it’s also been more difficult to accept what the fut